Mitomycin C can be a cost-effective alternative to BCG as intravesical treatment for intermediate ... NMIBC according to European Association of Urology criteria (IR-EAU group).

A recent study suggests that sequential intravesical treatment with gemcitabine ... as published in European Urology Oncology. Patients in the BCG group were 1.9 times more likely to undergo ...

Results of subgroup analyses of the phase 3 CREST trial (NCT04165317) evaluating sasanlimab plus BCG compared with BCG alone ...

Anorexia: a loss of appetite caused by illness or treatment, not the eating disorder. Hematuria: blood in the urine. “[Aidixi] plus BCG may potentially provide ... department of Urology, Fudan ...

In this trial, the RUTI vaccine was administered alongside the standard BCG treatment. The results were ... professor of urology and member of the EAU Scientific Congress Office.

7 Current treatment options for BCG-unresponsive patients are very limited ... medicine with a strong heritage in gastroenterology and urology, and are at the forefront of innovation in uro ...

An international trial found combining a chemotherapy drug with an immunotherapy bladder cancer treatment is simple, safe and effective.The trial was ...

U.S. Urology Partners is one of the first providers ... receptor agonist indicated with Bacillus Calmette-Guerin (BCG) for the treatment of adult patients with BCG-unresponsive non-muscle invasive ...

a Phase 3 clinical trial for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG) therapy. Cretostimogene is ...

U.S. Urology Partners is one of ... Supply shortages of TICE BCG in the U.S. have become a significant impediment to the treatment of bladder cancer patients. In a recent Sermo survey of 100 ...

In this trial, the RUTI vaccine was administered alongside the standard BCG treatment. The results were promising ... very promising results,” commented Joost Boormans, professor of urology and member ...